Progyny, Inc. · NASDAQ:PGNY
Progyny — JP Morgan Healthcare Conference 2025
18 slides from Progyny's conference presentation, January 2025
Slide 1: JP Morgan Conference
JP Morgan Conference January 2025 1 PLEASE REFER TO SLIDE 2 FOR THE SAFE HARBOR LANGUAGE REGARDING THIS PRESENTATION
Slide 2: Safe Harbor Statement
Safe Harbor Statement Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements cont
Slide 3: Progyny investment highlights
Progyny investment highlights Differentiated We have multiple Our proven model solution in a large pathways to creates meaningful and growing achieve our growth value for all market objectives constituencies Persistent demand through Our broadened offering is Our evidence-based solutions various mac
Slide 4: Progyny at a glance
Progyny at a glance 530+ 6.7M lives +82 NPS clients 9 years of 6+x 61x 99+% client superior increase increase retention clinical 45+ unique since IPO outcomes 15+ avg since since interactions industries inception inception 4 PLEASE REFER TO SLIDE 2 FOR THE SAFE HARBOR LANGUAGE REGARDING THIS PRESENT
Slide 5: Progyny is a mission-driven company
Progyny is a mission-driven company We believe in a world where everyone can realize their dreams of family and ideal health 5 PLEASE REFER TO SLIDE 2 FOR THE SAFE HARBOR LANGUAGE REGARDING THIS PRESENTATION
Slide 6: Achieving our mission through core pillars
Achieving our mission through core pillars Value-based care …delivers the right care, at the personalized to the individual… right time, for every member A data-driven approach to …produces sustained, plan design and benefit management… leading clinical outcomes Unparalleled level of collaboration a
Slide 7: Uniquely delivering on the promises of value-based care
Uniquely delivering on the promises of value-based care Across hundreds of thousands of journeys over the past nine years, our evidence- led approach in fertility and family building solutions has been proven to result in: higher treatment healthier healthier Reduced stress efficacy pregnancies babi
Slide 8: Creating value for clients, members and providers
Creating value for clients, members and providers Progyny’s fertility care delivery model is the only one in market with a documented history of delivering meaningful value to all constituencies Our treatment-based, Smart Cycle plan design: • Empowers doctors • Equitable across geographies • Provide
Slide 9: Providing the right care at the right time
Providing the right care at the right time Delivering a cohesive, connected experience for the member’s entire journey Preconception & Fertility & Pregnancy Menopause Trying-to-Conceive Family Building & Postpartum & Midlife Integrated benefit/claims management model Case rate model Case rate model
Slide 10: Relationships are the foundation for future growth
Relationships are the foundation for future growth Health Plans and PBMS Channel Partners Clients Clinical Partners 10 PLEASE REFER TO SLIDE 2 FOR THE SAFE HARBOR LANGUAGE REGARDING THIS PRESENTATION
Slide 11: Delivering across all the drivers of value creation that we can influence
Delivering across all the drivers of value creation that we can influence The significant drivers of our growth are areas that we have Illustration of revenue with utilization Reported revenue managed successfully every year since 2016, including: held constant at multi-year average $Ms 1,200 • Memb
Slide 12: Adding significant number of clients, maintaining diversity
Adding significant number of clients, maintaining diversity Adding substantial number of lives each year, The composition of our base by client size at a consistent average size also remains consistent Cumulative lives added since 2018 Average covered lives per new client won Distribution of Lives b
Slide 13: Sustained high levels of client retention
Sustained high levels of client retention Clients retained Clients attrited 500 • Since launching our solution in 2016, we have achieved an extraordinarily high 400 retention rate • Despite having a substantially larger 300 client base, we had our lowest number of absolute clients lost since 2021 20
Slide 14: Earning our way to deeper relationships with clients
Earning our way to deeper relationships with clients through our differentiation, proven ability to deliver value 20% 30% 40% 1.5 million of clients historically of clients expanded in 2025, of our newest clients covered lives with at grow their Progyny driven by our newest are including one or leas
Slide 15: Expanding our addressable market, adding opportunities
Expanding our addressable market, adding opportunities Expanding our addressable market Steady progression in Progyny market share (lives, in millions) (as % of 8,000 large, self-insureds in US) At IPO Today (2019) (2025) Future 180 ~156+ million + Global 160 ~7% 140 + ASO + Fully 120 insureds ~106
Slide 16: Strong cash flow enables our strategic capital priorities
Strong cash flow enables our strategic capital priorities Cumulative Operating Cash Flow 2020 – 2024 (through 9/30) Capital Priorities $500 Approaching half a • Continued evaluation of share billion in cumulative repurchases operating cash flow • Expand core business through $400 over past 5 years i
Slide 17: Women and Health
Specialized Conditions Women Ancillary Services PCOS and Health Mental Health Lactation & milk shipping Pregnancy A specialized benefits Pelvic floor platform created to Fertility & Sexual Health expedite interventions Endometriosis addressing Family Building Care Menopause interconnected Preeclamps
Slide 18: JP Morgan Conference
JP Morgan Conference January 2025 18 PLEASE REFER TO SLIDE 2 FOR THE SAFE HARBOR LANGUAGE REGARDING THIS PRESENTATION